Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Invivyd (IVVD) Research & Development (2023 - 2025)

Invivyd (IVVD) has disclosed Research & Development for 3 consecutive years, with $10.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 43.9% year-over-year to $10.0 million, compared with a TTM value of $38.3 million through Dec 2025, down 72.09%, and an annual FY2025 reading of $38.3 million, down 72.09% over the prior year.
  • Research & Development was $10.0 million for Q4 2025 at Invivyd, up from $8.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $62.3 million in Q4 2023 and bottomed at $8.0 million in Q3 2025.
  • Average Research & Development over 3 years is $27.9 million, with a median of $26.4 million recorded in 2023.
  • The sharpest move saw Research & Development surged 126.21% in 2024, then crashed 86.09% in 2025.
  • Year by year, Research & Development stood at $62.3 million in 2023, then tumbled by 71.24% to $17.9 million in 2024, then tumbled by 43.9% to $10.0 million in 2025.
  • Business Quant data shows Research & Development for IVVD at $10.0 million in Q4 2025, $8.0 million in Q3 2025, and $9.6 million in Q2 2025.